Stereotaxis Files Proxy Materials

TL;DR

STXS proxy filing is in, shareholders get the details.

AI Summary

Stereotaxis, Inc. filed a Definitive Additional Materials (DEFA14A) on April 8, 2024. This filing concerns proxy materials related to the company's operations and shareholder matters. The company is based in St. Louis, MO, and operates in the electromedical and electrotherapeutic apparatus industry.

Why It Matters

This filing provides shareholders with important information regarding company matters and voting rights, allowing them to participate in corporate governance.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not contain information that inherently increases risk for investors.

Key Players & Entities

• Stereotaxis, Inc. (company) — Registrant
• 0001493152-24-013599 (filing_id) — Accession Number
• 20240408 (date) — Filing Date
• 314-678-6100 (phone_number) — Business Phone

FAQ

Filing Documents

• formdefa14a.htm (DEFA14A) — 38KB
• 0001493152-24-013599.txt ( ) — 39KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 STEREOTAXIS, INC. (Name of the Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: Fee paid previously with preliminary materials. Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: STEREOTAXIS, INC. 710 North Tucker Boulevard Suite 110 St. Louis, Missouri 63101 (314) 678-6100 SUPPLEMENT DATED APRIL 8, 2024 TO THE PROXY STATEMENT DATED APRIL 4, 2024 FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 The following information relates to the 2024 Annual Meeting of Shareholders of Stereotaxis, Inc. (“Stereotaxis,” “we,” “us,” “our,” or the “Company”) and amends and supplements the related Definitive Proxy Statement filed with the Securities and Exchange Commission on April 4, 2024 (the “Proxy Statement”). The purpose of this filing is to correct and clarify information contained in the Proxy Statement relating to the effect of “broker non-votes” on (i) Proposal 3 to approve of an amendment to the Stereotaxis, Inc. 2022 Stock Incentive Plan (“2022 Stock Incentive Plan” or the “Plan”) to increase the shares authorized for issuance thereunder by 4,000,000 shares and (ii) Proposal 4 to approve of an amendment to the Employee Stock Purchase Plan (“2022 ESPP”) to increase the number of shares authorized for issuance under the 2022 ESPP by 250,000 shares, to 453,366. Rules of the New York Stock Exchange (“NYSE”) determine whether proposals are routine or non-routine. We expect that both Proposal 3 and Proposal 4 will be considered “non-routine”. Therefore, if you hold shares in street name through a broker or other nominee and do not vote your shares or provide voting instructions, your broker will not be allowed to vote your shares. This will result in a broker non-vote. Under our bylaws and Delaware law, broker non-votes are not counted as shares present and entitled to vote on the to correct and clarify the disclosures related to Proposal 3 and Proposal 4 relative to the foregoing. The first paragraph under the heading “Vote Required and Recommendation” for Proposal 3 on page 30 of the Proxy Statement is hereby amended to read as follows: “The affirmative vote of a majority of the shares present in person or by proxy and entitled to vote on the subject matter of this proposal will be required to approve the amendment of the 2022 Stock Incentive Plan. Because brokers are not permitted to vote on this proposal in the absence of voting instructions from beneficial owners, broker non-votes will have no effect on the outcome of this proposal. Abstentions will have the effect of negative votes.” The first paragraph under the heading “Vote Required and Recommendation” for Proposal 4 on page 34 of the Proxy Statement is hereby amended to read as follows: “The affirmative vote of a majority of the shares present in person or by proxy and entitled to vote on the subject matter of this proposal will be required to approve the amendment to the 2022 ESPP. Because brokers are not permitted to vote on this proposal in the absence of voting instructions from beneficial owners, broker non-votes will have no effect on the outcome of this proposal. Abstentions will have the effect of negative votes.” We urge you to read the Proxy Statement and this supplement in their entirety. Except as specifically supplemented by the information contained herein, all information in the Proxy Sta

View Full Filing

View this DEFA14A filing on SEC EDGAR